Lazard Asset Management LLC Reduces Stock Position in HealthEquity, Inc. $HQY

Lazard Asset Management LLC cut its position in HealthEquity, Inc. (NASDAQ:HQY) by 2.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 341,399 shares of the company’s stock after selling 9,893 shares during the period. Lazard Asset Management LLC’s holdings in HealthEquity were worth $28,531,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. Fifth Third Wealth Advisors LLC lifted its holdings in shares of HealthEquity by 4.2% during the first quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock worth $240,000 after purchasing an additional 116 shares during the period. Truist Financial Corp boosted its position in HealthEquity by 4.9% in the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock valued at $232,000 after buying an additional 119 shares during the last quarter. Fiduciary Trust Co increased its holdings in HealthEquity by 3.4% in the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after buying an additional 120 shares during the period. Larson Financial Group LLC increased its holdings in HealthEquity by 24.4% in the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after buying an additional 123 shares during the period. Finally, Merit Financial Group LLC raised its position in HealthEquity by 8.9% during the 3rd quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock worth $200,000 after buying an additional 172 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on HQY shares. Barrington Research restated an “outperform” rating and set a $110.00 price objective on shares of HealthEquity in a research note on Friday, May 22nd. Citizens Jmp increased their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research note on Monday, June 1st. Weiss Ratings raised shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Wells Fargo & Company set a $111.00 price objective on HealthEquity in a research note on Monday, June 1st. Eleven research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $110.93.

Insider Buying and Selling

In related news, Director Gayle Furgurson Wellborn sold 2,439 shares of the firm’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director owned 19,733 shares in the company, valued at approximately $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,354 shares of HealthEquity stock in a transaction on Friday, July 10th. The shares were sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the transaction, the executive vice president directly owned 52,244 shares of the company’s stock, valued at $4,963,180. The trade was a 4.31% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 17,905 shares of company stock valued at $1,651,280. Corporate insiders own 1.60% of the company’s stock.

HealthEquity Trading Up 2.2%

HealthEquity stock opened at $101.24 on Wednesday. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $105.96. The stock’s 50 day simple moving average is $90.87 and its two-hundred day simple moving average is $84.93. The firm has a market cap of $8.46 billion, a PE ratio of 37.92, a P/E/G ratio of 1.67 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.13. The firm had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. HealthEquity’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.